NCT03100136View on ClinicalTrials.gov

Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 16, 2016

Primary Completion Date

March 10, 2017

Study Completion Date

March 10, 2017

Conditions
Neuroinflammation
Interventions
DRUG

[11C]PF-06809247

PET Tracer

Trial Locations (3)

06511

Pfizer New Haven Clinical Research Unit, New Haven

06520

Anylan Center, New Haven

Yale University School of Medicine, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03100136 - Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer | Biotech Hunter | Biotech Hunter